Identifying a pathologic complete response (pCR) remains a primary goal for patients undergoing neoadjuvant therapy (NAT). Recent research highlights how a multiparametric MRI rectal cancer approach provides superior diagnostic accuracy compared to standard techniques. Consequently, clinicians can better differentiate between residual tumor tissue and post-radiation fibrosis. This distinction is vital for patients considering organ-preserving strategies like 'watch and wait'.

The retrospective study analyzed 152 patients with locally advanced rectal cancer (LARC) who underwent therapy followed by surgery. Researchers compared three distinct methods: T2-weighted imaging (T2WI) alone, biparametric MRI (T2WI and DWI), and multiparametric MRI (T2WI, DWI, and CE-T1WI). Specifically, they evaluated the area under the receiver operating characteristic curve (AUC) for each imaging protocol. Furthermore, they measured sensitivity and specificity against the gold standard of surgical histopathology results.

Improving Outcomes with Multiparametric MRI Rectal Cancer

Results showed that adding functional sequences significantly boosts diagnostic performance. The standard MRI-based tumor regression grade (mrTRG) achieved an AUC of 0.729. However, the biparametric approach increased this value to 0.840. Most notably, the full multiparametric model reached a high AUC of 0.891. Moreover, the sensitivity jumped from 0.481 to 0.815 when researchers integrated both CE-T1WI and DWI into the assessment. Therefore, this triple-modality assessment offers the most reliable way to confirm pCR before surgery.

Clinicians can utilize these findings to facilitate better decision-making for rectal cancer management. While T2WI provides anatomical detail, functional sequences reveal cellular density and vascularity changes. This comprehensive view helps identify the 17.8% of patients who achieve a total response. Consequently, these individuals may forgo radical surgery and avoid the associated morbidity of total mesorectal excision.

Frequently Asked Questions

What is pathologic complete response (pCR)?

Pathologic complete response occurs when no viable tumor cells remain in the resected specimen after neoadjuvant therapy. This status is associated with excellent long-term survival and may allow for non-operative management.

How does DWI improve MRI accuracy?

Diffusion-weighted imaging (DWI) measures the movement of water molecules within tissues. High cellularity in residual tumors restricts this movement, providing a clear contrast against the more permeable nature of fibrotic scars.

Can multiparametric MRI replace surgery?

While imaging helps identify pCR, it currently serves as a tool to select candidates for a 'watch and wait' strategy. This approach requires frequent monitoring with endoscopy and MRI to ensure the tumor does not recur.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Pan Y et al. Multiparametric MRI approach identifies pathologic complete response in patients with local advanced rectal cancer after neoadjuvant therapy. BMC Med Imaging. 2026 Feb 09. doi: 10.1186/s12880-026-02215-4. PMID: 41664004.

Lambregts GS, et al. MRI to guide clinical management of rectal cancer: updated consensus recommendations from the European Society of Gastrointestinal and Abdominal Radiology (ESGAR): PART II—Restaging and response evaluation. Eur Radiol. 2026. doi: 10.1007/s00330-025-11324-x.

Liao X et al. MRI-based radiomics for predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis. Front Oncol. 2025. doi: 10.3389/fonc.2024.1456333.